Fennec Pharmaceuticals Inc. (FENC) SEC Filings — 2024
19 SEC filings for Fennec Pharmaceuticals Inc. (FENC) in 2024.
Filings
- Fennec Pharmaceuticals Closes $3.02M Public Offering — 8-K · Dec 20, 2024
- Fennec Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Fennec Pharma Q3 2024: Assets Near Liabilities — 10-Q · Nov 8, 2024
- Fennec Pharmaceuticals Board Changes — 8-K · Oct 30, 2024
- Fennec Pharma 10-Q: Assets Near Liabilities — 10-Q · Aug 13, 2024
- Fennec Pharmaceuticals Board Shakeup — 8-K · Aug 7, 2024
- Fennec Pharmaceuticals Appoints New CMO and CSO — 8-K · Jul 2, 2024
- Fennec Pharmaceuticals Inc. SC 13G Filing — SC 13G · Jun 27, 2024
- Fennec Pharmaceuticals Files 8-K on Security Holder Votes — 8-K · Jun 25, 2024
- Fennec Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Fennec Pharmaceuticals Inc. Announces Annual Meeting of Shareholders on June 25, 2024 — DEF 14A · May 13, 2024
- Fennec Pharmaceuticals to be Acquired by Halozyme Therapeutics — 8-K · May 9, 2024
- Fennec Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
- Fennec Pharmaceuticals Files 8-K on Financials — 8-K · Mar 25, 2024
- Fennec Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 21, 2024
- Fennec Pharmaceuticals Files 8-K Amendment — 8-K/A · Mar 6, 2024
- Fennec Pharma Files 8-K on Other Events and Financial Exhibits — 8-K · Feb 29, 2024
- Fennec Pharmaceuticals Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Fennec Pharma Confirms Nasdaq Listing for Common Shares — 8-K · Feb 2, 2024